Catalyst Clinical Research Acquires Genpro Research
July 20, 2023
Catalyst Clinical Research, a Wilmington, North Carolina-based CRO and portfolio company of QHP Capital, has acquired Genpro Research, a Massachusetts-based clinical research organization with staff in the US, India, and Ireland. The deal adds more than 120 India-based team members and strengthens Catalyst's capabilities in biometrics/biostatistics, medical writing, real-world evidence (RWE)/HEOR, and AI-enabled automation.
- Buyers
- Catalyst Clinical Research
- Targets
- Genpro Research
- Platforms
- Catalyst Clinical Research
- Industry
- Healthcare Services
- Location
- Massachusetts, United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
Worldwide Clinical Trials Acquires Catalyst Clinical Research
February 17, 2026
Healthcare Services
Worldwide Clinical Trials, a Kohlberg-backed contract research organization, has completed its acquisition of Nottingham-based oncology specialist Catalyst Clinical Research from QHP Capital. The deal expands Worldwide's early-phase oncology, biometrics, and functional service provider (FSP) capabilities, creating a combined organization of roughly 4,400 employees across more than 70 countries; financial terms were not disclosed.
-
Catalyst Clinical Research Merges with Ce3, Inc.
August 5, 2020
Healthcare Services
Catalyst Clinical Research, a NovaQuest-backed CRO headquartered in Wilmington, North Carolina, has merged with Ce3, Inc., an early-phase oncology-focused CRO based in Clinton, Connecticut. The transaction combines Ce3's 15+ years of oncology expertise with Catalyst's broader clinical development and technology capabilities to create a next-generation oncology-focused CRO (add-on to Catalyst's NovaQuest-backed platform).
-
Catalyst Clinical Research Acquires Aptus Clinical
May 4, 2022
Healthcare Services
Catalyst Clinical Research, a portfolio company of NovaQuest Capital Management, has acquired U.K.-based Aptus Clinical to accelerate Catalyst's European expansion and broaden its oncology and early-phase clinical services. The deal creates a multi-region CRO operating across North America and Europe, increases Catalyst's patient reach by nearly 600 and lifts combined headcount to more than 800.
-
GHO Capital Acquires Genesis Research
November 16, 2021
Healthcare Services
London-based GHO Capital Partners has acquired Genesis Research, a Hoboken, New Jersey–headquartered provider of tech-enabled Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) services. The transaction, which follows a prior recapitalization by Rallyday Partners, gives Genesis additional capital and European market expertise to pursue global expansion and adjacent capability growth.
-
Network Partners Acquires The FlexPro Group, LLC
March 31, 2021
Healthcare Services
Network Partners, a Warsaw, Indiana-based life sciences professional services firm, has acquired The FlexPro Group, LLC, a Greater Philadelphia project management consulting firm focused on the life sciences. The deal adds FlexPro's 40+ consultants to Network Partners' ~175-member team to expand regulatory, project management and supply chain optimization capabilities for pharmaceutical and biotechnology clients.
-
Cressey & Company and Sunstone Partners Make Growth Investment in ProgenyHealth
May 20, 2025
Healthcare Services
ProgenyHealth, a Plymouth Meeting, Pennsylvania–based leader in maternity and NICU care management, received a significant growth investment from Cressey & Company alongside existing investor Sunstone Partners. The capital and Cressey's healthcare expertise will support ProgenyHealth’s continued expansion of its tech-enabled maternity and NICU care management services and platform.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.